Back to Journals » Journal of Asthma and Allergy » Volume 4 » default
![](https://www.dovepress.com/cr_data/cache/journal_image/27/cope/thumb_100_1000_100.jpg)
Journal of Asthma and Allergy
ISSN: 1178-6965
- View all (786)
- Volume 17, 2024 (52)
- Volume 16, 2023 (125)
- Volume 15, 2022 (151)
- Volume 14, 2021 (149)
- Volume 13, 2020 (77)
- Volume 12, 2019 (37)
- Volume 11, 2018 (31)
- Volume 10, 2017 (36)
- Volume 9, 2016 (25)
- Volume 8, 2015 (14)
- Volume 7, 2014 (14)
- Volume 6, 2013 (16)
- Volume 5, 2012 (10)
- Volume 4, 2011 (11)
- Volume 3, 2010 (20)
- Volume 2, 2009 (12)
- Volume 1, 2008 (6)
Archive: Volume 4, 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Childhood asthma and anthropogenic CO2 emissions
Dosanjh A
Journal of Asthma and Allergy 2011, 4:103-105
Published Date: 10 October 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Thioperamide induces CD4+ CD25+ Foxp3+ regulatory T lymphocytes in the lung mucosa of allergic mice through its action on dendritic cells
Amaral MM, Alvarez CA, Langellotti C, Jancic C, Salamone G, Geffner J, Vermeulen M
Journal of Asthma and Allergy 2011, 4:93-102
Published Date: 26 September 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Successful treatment of reactive airways dysfunction syndrome by high-dose vitamin D
Varney VA, Evans J, Bansal AS
Journal of Asthma and Allergy 2011, 4:87-91
Published Date: 22 September 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Clinical update on the use of biomarkers of airway inflammation in the management of asthma
Wadsworth SJ, Sin DD, Dorscheid DR
Journal of Asthma and Allergy 2011, 4:77-86
Published Date: 30 June 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Scientific Respiratory Symposium, Paris June 2010
Dalglish G, Priestley G
Journal of Asthma and Allergy 2011, 4:61-76
Published Date: 29 June 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Update on optimal use of omalizumab in management of asthma
Pelaia G, Gallelli L, Renda T, Romeo P, Busceti MT, Grembiale RD, Maselli R, Marsico SA, Vatrella A
Journal of Asthma and Allergy 2011, 4:49-59
Published Date: 13 June 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Effectiveness of inhaler types for real-world asthma management: retrospective observational study using the GPRD
Price D, Haughney J, Sims E, Ali M, von Ziegenweidt J, Hillyer EV, Lee AJ, Chisholm A, Barnes N
Journal of Asthma and Allergy 2011, 4:37-47
Published Date: 28 April 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Morning and evening efficacy evaluation of rupatadine (10 and 20 mg), compared with cetirizine 10 mg in perennial allergic rhinitis: a randomized, double-blind, placebo-controlled trial
Marmouz F, Giralt J, Izquierdo I
Journal of Asthma and Allergy 2011, 4:27-35
Published Date: 14 April 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Anti-inflammatory effects of pre-seasonal Th1-adjuvant vaccine to Parietaria judaica in asthmatics
Scichilone N, Minaldi C, Santagata R, Battaglia S, Camarda G, Bellia V
Journal of Asthma and Allergy 2011, 4:19-25
Published Date: 25 March 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The current role of sublingual immunotherapy in the treatment of allergic rhinitis in adults and children
Cristoforo Incorvaia, Simonetta Masieri, Silvia Scurati, et al
Journal of Asthma and Allergy 2011, 4:13-17
Published Date: 20 February 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
New therapies and management strategies in the treatment of asthma: patient-focused developments
Joshua Agbetile, Ruth Green
Journal of Asthma and Allergy 2011, 4:1-12
Published Date: 30 December 2010